Full Press Release Details
The Nu.Q® Vet Cancer Test is a simple, non-invasive blood test that enables early detection of cancer in dogs. Designed to be part of routine wellness checks, the test identifies circulating nucleosomes linked to cancer, delivering results within minutes (in-house) or just a few days (via reference labs). With 76% sensitivity for systemic cancers and 97% specificity, it offers a powerful tool to improve outcomes, lower treatment costs, and extend quality of life.
This comprehensive white paper goes beyond the science, including real-world case studies , veterinarian interviews , and pet owner testimonials that showcase the life-changing impact of early cancer detection.
Related Articles
• Press Releases Volition Announces Submission of Manuscript for Nu.Q® Vet Cancer Test in Cats. The publication of this study in a peer reviewed journal is expected subsequently to unlock a $5 million contractual milestone payment
• Press Releases Volition Announces First Ever Automated Nu.Q® Vet Cancer Test with Fujifilm Vet Systems
Volition Announces Submission of Manuscript for Nu.Q® Vet Cancer Test in Cats. The publication of this study in a peer reviewed journal is expected subsequently to unlock a $5 million contractual milestone payment
Volition Announces First Ever Automated Nu.Q® Vet Cancer Test with Fujifilm Vet Systems
• Share
• Tweet
• Share on Facebook
• Share
Subscribe for Volition product updates .
Or, click here for Investor Updates and press releases .
" * " indicates required fields